More info:

• isoniazid

  Isoniazid remains one of those foundational tuberculosis medications that’s been around for decades, yet still surprises me in clinical practice. When I first started working in our TB clinic back in 2012, I’ll admit I viewed it as just another antibiotic - but over the years, I’ve developed a real appreciation for its unique properties and the careful management it requires. Isoniazid: Essential Tuberculosis Treatment and Prevention - Evidence-Based Review 1.

• Antabuse: Aversive Therapy for Alcohol Use Disorder - Evidence-Based Review

  Disulfiram, known widely by its brand name Antabuse, is one of those medications that operates on a beautifully simple yet psychologically profound principle—it makes you violently ill if you drink alcohol. We’ve been using it in addiction medicine for decades, and honestly, it remains one of the most effective deterrent therapies when patients are truly committed to sobriety. It’s not a cure for alcoholism—nothing is—but it’s a powerful tool that gives people a concrete reason to resist that first drink.

• calcort

  Deflazacort, marketed under the brand name Calcort among others, is a synthetic corticosteroid belonging to the glucocorticoid class. It’s structurally similar to prednisolone but with an oxazoline ring substitution, which theoretically offers a better therapeutic index—meaning potentially similar efficacy with fewer side effects like fluid retention or glucose intolerance. We’ve been using it for decades, primarily as an anti-inflammatory and immunosuppressive agent. It’s not your run-of-the-mill supplement; this is a potent prescription medication indicated for conditions where you need to dial down the immune system’s overzealous response, think rheumatoid arthritis, asthma, or certain dermatological conditions.

• dilantin

  Phenytoin, known widely by its brand name Dilantin, is one of the foundational antiepileptic drugs in the neurologist’s arsenal. It’s not a new, flashy molecule; it’s a workhorse. For decades, its primary role has been the suppression of neuronal hyperactivity that leads to tonic-clonic and complex partial seizures. It’s a sodium channel blocker, pure and simple in its core mechanism, but its clinical use is anything but. The narrow therapeutic index, the complex pharmacokinetics, the myriad drug interactions—managing a patient on Dilantin is a practice in meticulous balancing.

• liv52

  For over six decades, practitioners have been reaching for this distinctive herbal formulation when facing complex hepatic challenges. Liv.52 represents one of those rare botanical preparations that managed to bridge traditional Ayurvedic wisdom with modern clinical practice, though its journey hasn’t been without controversy. I first encountered it during my hepatology rotation in the late 90s - an older gastroenterologist kept it in his desk drawer alongside his standard pharmaceutical arsenal.

• Myambutol: Targeted Tuberculosis Treatment with Ocular Monitoring Requirements - Evidence-Based Review

  Ethambutol hydrochloride, marketed under the brand name Myambutol among others, represents one of the first-line oral antimycobacterial agents specifically indicated for pulmonary tuberculosis. It’s not a dietary supplement but a prescription medication with a narrow therapeutic index, requiring careful clinical monitoring due to its potential ocular toxicity. The drug exists as a white, crystalline powder, stable at room temperature, and is typically administered in tablet form containing 100 mg or 400 mg of the active ingredient.

• trecator sc

  Ethionamide, marketed under the brand name Trecator SC, represents one of those second-line antituberculosis agents we reach for when first-line regimens fail or when we’re dealing with drug-resistant strains. It’s a synthetic compound derived from isonicotinic acid, structurally similar to isoniazid but with a sulfur atom replacing oxygen in the critical position - that single atom change makes all the difference in both activity spectrum and toxicity profile. We’ve been using this since the 1960s, and while it’s never been a first-choice medication due to its side effect burden, it remains absolutely essential in our MDR-TB and XDR-TB treatment protocols.

• abana

  Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in practice - a comprehensive herbal supplement with roots in Ayurvedic medicine, primarily indicated for cardiovascular support. What struck me during my early years at the Cleveland Clinic was how this multi-herb preparation kept appearing in patients’ medication lists, particularly among those with familial hyperlipidemia patterns. The formulation contains a sophisticated blend of Terminalia arjuna, Inula racemosa, Commiphora mukul, and several other botanicals that work synergistically - something we rarely see in single-component pharmaceuticals.

• abhigra

  Product Description: Abhigra represents a novel class of medical-grade nutraceutical devices that combines standardized botanical extracts with a patented sublingual delivery system. Unlike conventional supplements, its mechanism relies on transmucosal absorption bypassing first-pass metabolism, which we’ve observed yields significantly faster onset of action—particularly valuable for acute inflammatory episodes. The development team spent three years battling stability issues with the nanoemulsion matrix before discovering that alternating temperature cycles during production actually enhanced bioactive preservation, contrary to our initial assumptions.